The federal Ready, Set, PrEP program ended July 2025. Many websites still list it as active. See what replaced it →
Updated May 2026

Yeztugo (Lenacapavir) Cost: How Much Is the Twice-Yearly PrEP Injection?

Yeztugo is the first PrEP option that requires only two injections per year. It showed extraordinary clinical results — but the list price is $28,218/year. Here's what you'll actually pay and how to get it for $0.

Yeztugo Cost Breakdown

SituationYour CostDetails
List price (no insurance, no assistance)~$14,109/injection (~$28,218/year)Two subcutaneous injections per year after oral loading
Private insurance (ACA-compliant)$0Covered as preventive care — no copay, no deductible
Gilead Co-Pay Savings (commercially insured)$0Up to $8,000/year + $100/visit for injection administration
Gilead MAP (uninsured, ≤500% FPL)$0Free medication; no SSN required; FedEx overnight shipping
Medicaid$0Covered under preventive services; prior authorization may apply
Medicare Part BCost-sharing appliesManufacturer copay cards excluded; nonprofit funds may help
Bottom line: Despite the $28,218 annual list price, most people will pay $0 for Yeztugo. Insurance covers it under the ACA, and Gilead provides it free to qualifying uninsured patients.

Clinical Results

Yeztugo (lenacapavir) was approved by the FDA on June 18, 2025 — the first twice-yearly HIV prevention option. The clinical trial results were extraordinary:

The PURPOSE 1 trial in cisgender women showed zero HIV infections — 100% risk reduction. The PURPOSE 2 trial across a diverse population (cisgender men, transgender men, transgender women, and gender non-binary individuals) showed only 2 infections — a 96% risk reduction. Science magazine named lenacapavir the 2024 Breakthrough of the Year.

How to Get Yeztugo for Free

If you have commercial insurance: PrEP is covered at $0 under the ACA. If your plan charges anything, Gilead's Co-Pay Savings Program covers up to $8,000/year in out-of-pocket costs plus $100 per visit for injection administration. No income restriction. Call 1-877-505-6986 or visit prep.advancingaccess.com.

If you're uninsured: Gilead's Medication Assistance Program (MAP) provides Yeztugo free to patients with income at or below 500% of the Federal Poverty Level (~$79,800/year for an individual). No SSN required. Medication can ship via FedEx overnight. Call 1-800-226-2056 or visit gileadadvancingaccess.com.

If you're on Medicaid: Yeztugo is covered as a preventive service at $0 cost-sharing. Prior authorization may be required given the high list price. Your provider handles the paperwork.

Yeztugo vs. Apretude: Injectable PrEP Comparison

Yeztugo (Lenacapavir)Apretude (Cabotegravir)
ManufacturerGilead SciencesViiV Healthcare
FrequencyEvery 6 monthsEvery 2 months
Injection typeSubcutaneous (belly area)Intramuscular (gluteal)
Annual list price~$28,218~$24,000
Annual visits2 (after loading)6 (after loading)
Free for uninsured?Yes — Gilead MAPYes — ViiVConnect PAP
ApprovedJune 2025December 2021
Is the 6-month injection cheaper than Apretude? At list price, Yeztugo costs more annually (~$28K vs ~$24K). But both are covered at $0 with insurance or patient assistance, so the practical cost difference is zero for most people. The real advantage is convenience: 2 visits per year instead of 6.

Skip the cost — get PrEP delivered free with MISTR

MISTR provides $0 PrEP in all 50 states — consultations, at-home labs, medication, and delivery included. Works with or without insurance.

ANDR735

Using this code helps sustain FreePrEP.org and fund free PrEP access for others.

Insurance Coverage Status

CMS approved HCPCS J-codes for Yeztugo effective October 1, 2025, which means Medicare, Medicaid, and commercial plans can now process claims. Most private insurers are covering it under the ACA preventive care mandate, though prior authorization is common given the high cost.

If your insurer denies coverage or requires excessive prior authorization, your provider can appeal. Gilead also has a dedicated support team to help with insurance issues: 1-800-226-2056.

What's Next: Once-Yearly Lenacapavir

Gilead has a once-yearly lenacapavir formulation in Phase III clinical trials, with results expected around 2028. If approved, PrEP could become a single annual injection. Generic lenacapavir production is also expected by 2027 for lower-income countries at roughly $40 per person per year through agreements with the Gates Foundation and Unitaid.

Frequently Asked Questions

How much does Yeztugo cost without insurance?
List price is approximately $14,109 per injection (~$28,218/year). However, Gilead's Medication Assistance Program provides it free to uninsured patients with income under 500% FPL. No SSN required. Call 1-800-226-2056.
Does insurance cover Yeztugo?
Yes. Under the ACA, private insurance must cover all FDA-approved PrEP medications at $0. Medicaid also covers Yeztugo. CMS approved billing codes effective October 2025. Prior authorization may be required.
Can I switch from Apretude to Yeztugo?
Yes — talk to your provider about timing. Both are injectable PrEP but they use different drugs and injection schedules. Your provider can coordinate the transition to ensure continuous protection. There should be no gap in coverage if timed correctly.

Information sourced from manufacturer websites, FDA prescribing information, CMS, NASTAD, and state health departments. FreePrEP.org is an independent resource — not affiliated with any government agency or pharmaceutical company. Full disclosure